1 Mo rales MA, Ferdeg hini EM, Pizzarelli F, et al.Characterization of myo cardial tissue in patients undergoing maintenance hemodialy sis by quantitative echocardiography.J Am Soc Echocardiogr, 1996;9:480
2 Sistopolsky E, Berkoben M, Kelber J, et al.Effect of calcitrio l and moncalcemic vitamin D analogs on secondary hyperparathy roidism.Kidney Int, 1992;28(suppl):S43
3 Tsukamoto Y, Mijares RP.The oral 1, 25(OH) 2D3pulse therapy in hemodialy sis patients with severe secondary hyperparathy oidism.Nephro n, 1991;57:23
4 Fetchik DA, Ber tolini DR, Sarin PS, et al.Production of 1, 25-dihydro xy vitamin D3 by human T cell lymphotropic virus-I-transformed lymphocetes.J Clin Invest, 1986;78: 592
5 Reichel H, Koeffler HP, Norman AW, et al.The role of the vitamin D endocrine system in health and disease.N Engl J Med, 1989;320:980
6 Littledike ET, Horst RL.Metabolism of vitamin D3 in nephrectomized pigs given pharmacological amounts of vitamin D3.Endocrinolog y, 1982;111:2008
7 孙琛.临床用药大全.第1 版.上海:中国大百科全书出版 社, 1995:4401 |
